Jeffrey Silva, Director of Product Development, Adeptrix Corporation discusses BAMS™ Assay Platform

Posted by

Bruker Mass Spectrometry

1,544 views

|

January 26, 2021

Add to Playlist

Jeffrey explained how BAMS™ Assay Platform simplifies the process for targeted- and discovery-based proteomic applications, by replacing the need for liquidchromatography separation methods in the analysis of complex biological samples by utilizing affinity enrichment (e.g. antibody-based) directed to specific target proteins, prior to MS analysis.

Analytical Techniques Mass Spectrometry Proteomics and Metabolomics

Up Next

Autoplay

More Videos from Bruker Mass Spectrometry

MALDI Mass Spectrometry of Synthetic Polymers

Bruker Mass Spectrometry

8 months ago

Analytical Techniques Environmental Monitoring Environmental Science Imaging/Microscopy

Bruker Mass Spec Virtual Live Demo: MALDI IHC Imaging in whole tissue sections

Bruker Mass Spectrometry

8 months ago

Cancer Research Imaging/Microscopy Proteomics and Metabolomics

Live from the Lab at Sapient: How timsTOF is helping to transform the speed and scale of small molecule biomarker discovery

Bruker Mass Spectrometry

8 months ago

Analytical Techniques Mass Spectrometry Next-Generation Sequencing Proteomics and Metabolomics

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.

Subscribe To Newsletter Image